Abstract Details

Title Progressive multiple sclerosis patients with NFKBIA mutations are less responsive to the immune changes induced by treatment with MIS416

Topic Multiple Sclerosis

Presentation(s) P2 - (-)

Poster/Presentation
Number 349

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Pamela A. McCombe, MD (Dr PA McCombe Medical Pty Ltd) PRESENTER	Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. The institution of Dr. McCombe has received research support from Motor Neurone Disease Resaerch Institute of Australia.
	No disclosure on file
Gill Webster, PhD	No disclosure on file
	No disclosure on file

��ɫ��